Heard on the Hill

House Ways and Means Comments on Drug Price Controls

House Ways and Means Committee Chairman Jason Smith (MO-08) comments on the Biden-Harris Administration’s recent announcement regarding price controls for ten specific medications. In his 8/15/2024 press release, Smith cites the cost increases and research and development impediments expected to result from the price-setting move. Read the full press release here…

This posting is presented for informational purposes only and does not represent legal or financial guidance. Any opinions or interpretations presented are either those of the original author or, in the case of articles authored by the AMAC Foundation, are the opinions of AMAC Foundation staff, originally trained and accredited by the National Social Security Association (NSSA) and certified via the AMAC Foundation. Any links included in the article are valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the links’ validity. NSSA and the AMAC Foundation and its staff are not affiliated with or endorsed by the Social Security Administration or any other governmental entity. To submit a question, visit our website (https://amacfoundation.org/services/) or email us at ssadvisor@amacfoundation.org. Because we are a non-profit organization, there is no charge for these services.

Website by Geiger Computers